[Minimally invasive surgery for centrally located lung cancers]

Area of Science:

• Thoracic Surgery
• Surgical Oncology
• Pulmonology

Background:

• Minimally invasive surgery (MIS) enhances recovery and quality of life by reducing trauma and pain.
• MIS, including video-assisted thoracoscopic surgery (VATS) and robotic surgery, is standard for early-stage peripheral lung cancers.
• Central lung cancers present surgical challenges, often necessitating open thoracotomy for complex procedures like sleeve lobectomy or pneumonectomy.

Purpose of the Study:

• To evaluate the feasibility and safety of MIS for central lung cancers.
• To explore the potential of MIS in complex pulmonary resections.
• To compare MIS with open thoracotomy for central lung tumors.

Main Methods:

• Review of current surgical techniques for central lung cancer.
• Analysis of initial outcomes for MIS in sleeve lobectomy and pneumonectomy for central lung cancers.
• Comparison of MIS approaches with traditional open thoracotomy.

Main Results:

• MIS techniques are being increasingly applied to central lung cancers.
• Initial results indicate feasibility and safety of MIS for sleeve lobectomy and pneumonectomy in central lung cancer cases.
• MIS demonstrates significant potential for treating central lung tumors.

Conclusions:

• MIS is a viable option for complex central lung cancer resections.
• Further studies are required to establish functional superiority and oncological equivalence to open surgery.
• Expanding MIS for central lung cancers could benefit a larger patient population.